Literature DB >> 2502562

Expression of gamma interferon on circulating lymphocytes in viral infections.

A Caruso1, R Stellini, A Scalzini, P Pollara, I Foresti, C Bonfanti, G Scura, R Gonzales, N Manca, A Turano.   

Abstract

Peripheral blood lymphocytes from a total of 111 patients and 40 healthy individuals were studied for gamma interferon (IFN-gamma) expression on their surfaces by indirect immunofluorescence assay and flow cytometry, with a new anti-IFN-gamma monoclonal antibody (IGMB-14) as a specific reagent. Of 64 patients with proven acute viral infections, 59 had a significantly higher percentage of lymphocytes expressing IFN-gamma on their membranes than healthy individuals did. On the other hand, only 3 (8.9%) of 34 patients with proven bacterial infections had an increased percentage of IFN-gamma-expressing lymphocytes. None of the eight patients with other infections and none of the five with systemic lupus erythematosus showed an increased percentage of IFN-gamma-positive lymphocytes. The percentage of IFN-gamma-expressing lymphocytes during a viral infection was found to be related to different stages of the disease. Finally, some applications of this rapid IFN-gamma assay method in viral diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502562      PMCID: PMC267580          DOI: 10.1128/jcm.27.6.1426-1429.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  CIRCULATING INTERFERON-LIKE VIRAL INHIBITOR IN PATIENTS WITH MENINGITIS DUE TO HAEMOPHILUS INFLUENZAE.

Authors:  R H MICHAELS; M M WEINBERGER; M HO
Journal:  N Engl J Med       Date:  1965-06-03       Impact factor: 91.245

2.  Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA.

Authors:  P H Van der Meide; M Dubbeld; H Schellekens
Journal:  J Immunol Methods       Date:  1985-05-23       Impact factor: 2.303

3.  How useful are serum and CSF interferon levels as a rapid diagnostic aid in virus infections?

Authors:  D Flowers; G M Scott
Journal:  J Med Virol       Date:  1985-01       Impact factor: 2.327

4.  Non-production of interfering substances by serum from patients with infectious hepatitis.

Authors:  P E Taylor; A J Zuckerman
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

5.  Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis.

Authors:  D A Hill; J H Walsh; R H Purcell
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

6.  Inhibition of anticellular activity of mouse gamma interferon by an inhibitor of interferon action.

Authors:  W R Fleischmann; C E Kirst; C M Fleischmann
Journal:  J Interferon Res       Date:  1984

7.  Evaluation of the expression of IFN-gamma in lymphocytes using a monoclonal antibody and flow cytometry.

Authors:  A Caruso; L Terlenghi; A Scalzini; R Verardi; I Foresti; P Pollara; C Bonfanti; G Ravizzola; N Manca; A Turano
Journal:  J Immunol Methods       Date:  1988-10-04       Impact factor: 2.303

8.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

9.  A two-site sandwich radioimmunoassay of human gamma interferon with monoclonal antibodies.

Authors:  E Tanaka; M Imai; S Usuda; K Tachibana; H Okamoto; Y Ohike; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

10.  Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report.

Authors:  M G Ikossi-O'Connor; J L Ambrus; T West; M A Lillie; H Milgrom; K C Chadha
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.